台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberPRAN-16-52

2017-08-01 - 2022-12-31

Phase III

Terminated7

ICD-10C92.A0

Acute myeloid leukemia with multilineage dysplasia, not having achieved remission

Trial Applicant

Clinipace Taiwan Co., Ltd
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2025/08/20

Investigators and Locations

Principal Investigator Sheng-chieh Chou Division of General Internal Medicine

National Taiwan University Hospital

Co-Principal Investigator

劉家豪 Division of General Internal Medicine
Tai-Chung Huang Division of General Internal Medicine
- - Division of General Internal Medicine
Wen-Chien Chou Division of General Internal Medicine
Huai-Hsuan Huang Division of General Internal Medicine
林建廷 Division of General Internal Medicine
- - Division of General Internal Medicine
Chieh-Lung Cheng Division of General Internal Medicine
CHENG-HONG TSAI Division of General Internal Medicine
Jih-Luh Tang Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Principal Investigator 賴冠銘 Division of Hematology & Oncology

CHANGHUA CHRISTIAN HOSPITAL

Co-Principal Investigator

林敬業 Division of Hematology & Oncology
林炫聿 Division of Hematology & Oncology
曾若涵 Division of Hematology & Oncology
王全正 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Su-Peng Yeh Division of Hematology & Oncology

China Medical University Hospital

Co-Principal Investigator

Che-Hung Lin Division of Hematology & Oncology
Ching-Chan Lin Division of Hematology & Oncology
Ming-Yu Lien Division of Hematology & Oncology
Chi-Ching Chen Division of Hematology & Oncology
Ming-Hung Tsai Division of Hematology & Oncology
Tzu-Ting Chen Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Hung Chang Division of Hematology & Oncology

Linkou Chang Gung Medical Foundation

Co-Principal Investigator

Po-Nan Wang Division of Hematology & Oncology
Ming-Chung Kao Division of Hematology & Oncology
Tung-Liang Lin Division of Hematology & Oncology
高小雯 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 馬銘君 Division of Hematology & Oncology

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

裴松南 Division of Hematology & Oncology
廖浚凱 Division of Hematology & Oncology
王銘崇 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 譚傳德 Division of Hematology & Oncology

Koo Foundation Sun Yat-Sen Cancer Center

Co-Principal Investigator

陳鵬宇 Division of Hematology & Oncology
吳茂青 Division of Hematology & Oncology
邱倫瑋 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Hui-Hua Hsiao Division of Hematology & Oncology

Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital

Co-Principal Investigator

Hui-Ching Wang Division of Hematology & Oncology
Yi-Chang Liu Division of Hematology & Oncology
Jeng-Shiun Du Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Su-Peng Yeh 未分科

China Medical University Hospital-Taipei

Co-Principal Investigator

Audit

CRO

Principal Investigator

Kaohsiung Municipal Gangshan Hospital

Co-Principal Investigator

Hui-Hua Hsiao 未分科

Audit

None

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

Taiwan

40 participants
Global

500 participants